Results 71 to 80 of about 223,878 (259)

Mr Parkinson, Mr Zimmerman, and Mr Teal, Parkinson in Person seminar, 1981

, 1981
Professor Northcote Parkinson (left) at a seminar "How to help your executives communicate better". Held at the Australian Institute of Management. Pictured with Mr Parkinson are Mr L.
Swinburne Institute of Technology
core   +1 more source

Global Rather Than Vertical‐Selective Saccadic Abnormalities in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To test whether vertical saccades are preferentially affected in Progressive Supranuclear Palsy (PSP). Methods PSP patients (n = 24) were compared to age‐matched controls (n = 94) and two degenerative groups (Alzheimer's disease, n = 20; Lewy body disease, n = 50).
Duy Duan Nguyen, Mark Paine, Soohyun Lee, Amir Fazlollahi, Baibin (Ben) Wang, John D. O'Sullivan, Peter J. Nestor   +6 more
wiley   +1 more source

ALTERAÇÕES RESPIRATÓRIAS EM INDIVÍDUOS COM DOENÇA DE PARKINSON [PDF]

, 2016
A Doença de Parkinson (DP) foi descrita pela primeira vez em 1817 por James Parkinson como uma doença de progressão lenta, perda gradual dos movimentos voluntários, rigidez muscular e tremor.
Silva, Karina Martin Rodrigues, Lopes, Rodrigo Henrique Ferreira, Maia, André Benetti da Fonseca   +2 more
core   +1 more source

GRID SEARCH AND RANDOM SEARCH HYPERPARAMETER TUNING OPTIMIZATION IN XGBOOST ALGORITHM FOR PARKINSON’S DISEASE CLASSIFICATION

Barekeng
Parkinson's disease is a neurodegenerative disorder affecting motor abilities, with a prevalence of 329 cases per 100,000 individuals. Early diagnosis is crucial to prevent complications.
Shafa Fitria Aqilah Khansa, Nurissaidah Ulinnuha, Wika Dianita Utami   +2 more
doaj   +1 more source

CAPACIDADE FUNCIONAL EM IDOSOS COM DOENÇA DE ALZHEIMER E DOENÇA DE PARKINSON: REVISÃO BIBLIOGRÁFICA

Revista Pesquisa em Fisioterapia, 2014
Introdução: O processo de envelhecimento é considerado um fenômeno biológico, psicológico e social, podendo ser acompanhado por diversas alterações progressivas.
Itamara Prado Souza, Lidiane Meneses dos Santos, Viviane Santos Santana, Alexandre Gomes Feitosa   +3 more
doaj   +1 more source

Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali, Priyanka Menon, Halil I. Corbali, Ram Jagannathan, Allan I. Levey   +4 more
wiley   +1 more source

Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton, Carol Hermon, Sarah Floud, Gillian Reeves, Isobel Barnes   +4 more
wiley   +1 more source

Multicomponent reactions driving the discovery and optimization of agents targeting central nervous system pathologies

Beilstein Journal of Organic Chemistry
The ongoing quest to discover effective treatments for diseases remains a significant challenge for the scientific community. Multicomponent reactions (MCRs) have emerged as powerful tools in accelerating drug discovery, enabling the rapid generation of ...
Lucía Campos-Prieto, Aitor García-Rey, Eddy Sotelo, Ana Mallo-Abreu   +3 more
doaj   +1 more source

Professor Northcote Parkinson, Parkinson in Person seminar, 1981 -- 02

, 1981
Professor Northcote Parkinson at a seminar "How to help your executives communicate better".
Swinburne Institute of Technology
core  

Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay, Merve Alaylioglu, Erdi Sahin, Sanem Sultan Yoruk Oner, Gulce Iskan, Gulce Cosku Yilmaz Cakan, Gozde Kizilates‐Evin, Emre Hari, Elif Kurt, Erdinc Dursun, Basar Bilgic, Hasmet Hanagasi, Hakan Gurvit, Tamer Demiralp, Duygu Gezen‐Ak, Bedia Samanci   +15 more
wiley   +1 more source